Pharmacokinetics of High-Dose Lopinavir-Ritonavir with and without Saquinavir or Nonnucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus-Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors

Human immunodeficiency virus (HIV)-infected children and adolescents who are failing antiretrovirals may have a better virologic response when drug exposures are increased, using higher protease inhibitor doses or ritonavir boosting. We studied the pharmacokinetics and safety of high-dose lopinavir-...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Robbins, Brian L., Capparelli, Edmund V., Chadwick, Ellen G., Yogev, Ram, Serchuck, Leslie, Worrell, Carol, Smith, Mary Elizabeth, Alvero, Carmelita, Fenton, Terence, Heckman, Barbara, Pelton, Stephen I., Aldrovandi, Grace, Borkowsky, William, Rodman, John, Havens, Peter L.
פורמט: Artigo
שפה:Inglês
יצא לאור: American Society for Microbiology (ASM) 2008
נושאים:
Clinical Therapeutics
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2533475/
https://ncbi.nlm.nih.gov/pubmed/18625762
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00224-08
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים